BUSINESS

• Pfizer Japan Files BCMA Bispecific Elranatamab for MM
  June 30, 2023

• CAR-T Player Noile-Immune Goes Public on TSE
  June 30, 2023

• Shionogi Launches PIII Pediatric Study for Xocova in Japan
  June 30, 2023

• Takeda CEO Touts Aggressive Dividend Policy as Deleveraging Drive Hits Goal
  June 29, 2023

• Chugai Trims 150 Reps via Voluntary Buyout, Sales Force Down to 1,050 from July
  June 29, 2023

• Astellas’ Hot Flash Med Nets Positive PIIIb Results in Europe
  June 29, 2023

• Takeda CEO Earns 1.72 Billion Yen in FY2022, Down 135 Million Yen
  June 29, 2023

• Keytruda Label Updated to Add Hodgkin Lymphoma Data
  June 28, 2023

• UN-Backed Agency, 7 Firms Ink Deals for Generic Supply of Shionogi’s COVID Pill to LMICs
  June 28, 2023

• Taiho, Kyushu University in Research Tie-Up on Covalent Reactive Groups
  June 28, 2023

• Meiji Seika Pharma Files GVHD Drug Belumosudil in Japan
  June 28, 2023

• UCB Japan Seeks Lennox-Gastaut Syndrome Indication for Fintepla
  June 28, 2023

• Chugai to Form Corporate VC in Boston to Drive Innovation
  June 28, 2023

• UBE, IPSC Startup Grab US Orphan Tag for IPF Therapy
  June 28, 2023

• Rexulti Makes Mark in Japan PIII Study for Alzheimer’s Agitation: Otsuka
  June 28, 2023

• Merck Biopharma, Pfizer Japan to End Bavencio Copromotion
  June 28, 2023

• Amgen Japan to Cut 30 Jobs in Evenity Sales Unit as It Rejigs Organization
  June 27, 2023

• Japan Approves Novartis’ Gene Therapy Luxturna for Rare Eye Disease
  June 27, 2023

• Lonsurf-Bevacizumab Combo Nabs EU Panel Nod for Colorectal Cancer
  June 27, 2023

• Shionogi Snaps Up Qpex to Boost Antimicrobial Pipeline
  June 27, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 130
• 131
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• …
• Next ›
• 最終 »